Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.6459
-0.2085 (-24.40%)
At close: Jan 23, 2026, 4:00 PM EST
0.6195
-0.0264 (-4.09%)
After-hours: Jan 23, 2026, 7:59 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $3.83 million as of January 23, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
3.83M
Enterprise Value
-8.88M
1-Year Change
-25.14%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.83M, a decrease of -95.77%. That is a compound annual growth rate of -45.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.83M | -19.24% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 5.46M |
| BiomX | 5.45M |
| Cyclerion Therapeutics | 5.25M |
| VivoSim Labs | 5.23M |
| GeoVax Labs | 4.95M |
| Silo Pharma | 4.91M |
| Aspire Biopharma Holdings | 4.86M |
| Decoy Therapeutics | 4.79M |